Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longchuan Bai

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Annual Review of Medicine|November 6, 2013
Targeting apoptosis pathways for new cancer therapeuticsLongchuan Bai, Shaomeng Wang
Biochemical and Biophysical Research Communications|June 15, 2007
ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrateLongchuan Bai, Juanita L Merchant
FEBS Letters|December 7, 2007
A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasionLongchuan Bai, Juanita L Merchant
Nucleic Acids Research|December 5, 2003
Transcription factor ZBP-89 is required for STAT1 constitutive expressionLongchuan Bai, Juanita L Merchant
Oncotargets and Therapy|November 15, 2018
MCL-1 inhibition in cancer treatmentWeiguo Xiang, Chao-Yie Yang, Longchuan Bai
Pharmacology & Therapeutics|May 21, 2014
Small-molecule SMAC mimetics as new cancer therapeuticsLongchuan Bai, David C Smith, Shaomeng Wang
International Journal of Gastrointestinal Cancer|March 8, 2003
Regulation of epithelial cell growth by ZBP-89: potential relevance in pancreatic cancerLongchuan Bai, Craig Logsdon, Juanita L Merchant
The Journal of Nutrition|July 4, 2003
ZBP-89 mediates butyrate regulation of gene expressionJuanita L Merchant, Longchuan Bai, Morihiro Okada
Drug Discovery Today. Technologies|June 16, 2019
Small-molecule PROTAC degraders of the Bromodomain and Extra Terminal (BET) proteins - A reviewChao-Yie Yang, Chong Qin, Longchuan Bai, et al.
Anticancer Research|July 11, 2006
P53 mutants suppress ZBP-89 functionMorihiro Okada, Arthur Tessier, Longchuan Bai, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Annual Review of Medicine|November 6, 2013
Targeting apoptosis pathways for new cancer therapeuticsLongchuan Bai, Shaomeng Wang
Biochemical and Biophysical Research Communications|June 15, 2007
ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrateLongchuan Bai, Juanita L Merchant
FEBS Letters|December 7, 2007
A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasionLongchuan Bai, Juanita L Merchant
Nucleic Acids Research|December 5, 2003
Transcription factor ZBP-89 is required for STAT1 constitutive expressionLongchuan Bai, Juanita L Merchant
Oncotargets and Therapy|November 15, 2018
MCL-1 inhibition in cancer treatmentWeiguo Xiang, Chao-Yie Yang, Longchuan Bai
Pharmacology & Therapeutics|May 21, 2014
Small-molecule SMAC mimetics as new cancer therapeuticsLongchuan Bai, David C Smith, Shaomeng Wang
International Journal of Gastrointestinal Cancer|March 8, 2003
Regulation of epithelial cell growth by ZBP-89: potential relevance in pancreatic cancerLongchuan Bai, Craig Logsdon, Juanita L Merchant
The Journal of Nutrition|July 4, 2003
ZBP-89 mediates butyrate regulation of gene expressionJuanita L Merchant, Longchuan Bai, Morihiro Okada
Drug Discovery Today. Technologies|June 16, 2019
Small-molecule PROTAC degraders of the Bromodomain and Extra Terminal (BET) proteins - A reviewChao-Yie Yang, Chong Qin, Longchuan Bai, et al.
Anticancer Research|July 11, 2006
P53 mutants suppress ZBP-89 functionMorihiro Okada, Arthur Tessier, Longchuan Bai, et al.
Pageof 7